Ralph Brandenberger

Dr. Brandenberger joined Nkarta in 2018 and oversees the company’s cell therapy manufacturing operations. He has broad experience in process development, technical operations and manufacturing of cellular therapeutics and biologics. He was previously at Neurona Therapeutics, where he developed the manufacturing strategy for Neurona’s novel cell therapy platform. Prior to that, Dr. Brandenberger oversaw manufacturing sciences, analytical sciences and GMP cell banking as Head of Technical Operations at Baxalta Hayward, a GMP manufacturing plant of clinical stage biologics and reagents used in commercial drug substance manufacturing. Prior to joining Baxalta, Dr. Brandenberger served as Director of Process Sciences for Cellular Therapeutics at Geron Corporation where he had responsibilities for process and technology development of Geron’s pluripotent stem cell platform.

Dr. Brandenberger received a MS and PhD in Cell Biology from the Biocenter of the University of Basel, Switzerland. He completed postdoctoral training at the Howard Hughes Medical Institute at the University of California, San Francisco.